Shear-Induced Pathway of Platelet Function in Cardiac Surgery

Abstract

The contribution of platelet dysfunction to the impaired hemostasis after cardiac surgery remains to be established, because there is no sensitive method to assess platelet function. Measurement of the shear-induced pathway of platelet function, an important mechanism in inducing hemostasis, became possible by a novel shear-inducing technique, the in-vitro bleeding test (Thrombostat 4000). By using this test, the changes in platelet function during cardiopulmonary bypass and their contribution to hemostasis were investigated in patients undergoing cardiac surgery. Platelet function is quickly impaired shortly after the start of cardiopulmonary bypass, and partly recovered at the end of cardiopulmonary bypass. The function of aspirin-treated platelets is more severely affected than of nonaspirin platelets during cardiopulmonary bypass. Furthermore, the degree of platelet dysfunction at the end of the operation, but neither the platelet number nor the activated clotting time, was significantly correlated with blood loss from the chest drain after cardiac surgery. These results indicate the significant and variable effects of cardiopulmonary bypass on the shear-induced pathway of platelet function. Moreover, the impairment of this function of platelets appears to be a major cause of excessive bleeding in patients after cardiac surgery. Therefore, the routine use of the shear-inducing test seems helpful to make a proper diagnosis and design the therapy for bleeders after cardiac surgery.

Keywords

cardiopulmonary bypass - cardiac surgery - hemostasis - platelet function - shear-stress - Thrombostat

• References

• 1 Harker LA, Malpass TW, Branson HE, Hessel EA, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass. Blood 56: 824-834 1980;
• 2 Harker LA. Bleeding after cardiopulmonary bypass. N Engl J Med 314: 1446-1447 1986;
• 3 Khuri SF, Wolfe JA, Josa M, Axford TC, Szymanski I, Assousa S, Ragno G, Patel M, Silverman A, Park M, Valeri CR. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and non-surgical blood loss. J Thorac Cardiovasc Surg 104: 94-107 1992;
• 4 Goldman S. Veterans Administration Group. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy. Circulation 77: 1324-1332 1988;
• 5 Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Eliis PA, MacGregor H, Birjiniuk V, Ouimet H, Pasche B, Nelson MJ, Benoit SE, Rodino U, Barnard MR, Michelson AD. The platelet function defect of cardiopulmonary bypass. Blood 82: 107-117 1993;
• 6 Bick RL. Platelet function defects: a clinical review. Semin Thromb Hemost 18: 167-185 1992;
• 7 O'Brien JR, Salmon GP. Shear-stress activation of platelet glycoprotein rIb/UIa plus von Willebrand factor causes aggregation. Blood 70: 1354-1361 1987;
• 8 Berliner S, Niinga K, Roberts JR, Houghton A, Ruggeri ZM. Generation and characterization of peptide-specific antibodies that inhibit vWF factor binding to glycoprotein IIb/IIIa without interacting with other adhesive molecules. J Biol Chern 263: 7500-7505 1988;
• 9 Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffman T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb/IIIa complex at high shear rate. J Clin Invest 83: 288-297 1989;
• 10 Badimon L, Badimon JJ, Turitto VT, Fuster V. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate. Blood 73: 961-967 1989;
• 11 Sakariassen KS, Nievelstein PFEM, Coller BS, Sixma JJ. The role of platelet membrane glycoprotein Ib and IIb-UIa in platelet adherence to human artery subendothelium. Br J Haematol 63: 681-691 1986;
• 12 O'Brien JR. Shear-induced platelet aggregation. Lancet 335: 771-773 1990;
• 13 Kratzer MMA, Born GVR. Simulation of primary hemostasis in vitro. Haemostasis 15: 357-362 1985;
• 14 Kratzer MAA, Bellucci S, Caen JP. Detection of abnormal platelet function with an in vitro model of primary hemostasis. Haemostasis 15: 363-370 1985;
• 15 Tabuchi N, de Haan J, van Oeveren W. Rapid recovery of platelet function after cardiopulmonary bypass. Blood 82: 2930-2931 1993;
• 16 Tabuchi N, Huet RCCG, Sturk A, Eijsman L, Wildevuur ChRH. Hemostatic function of aspirin-treated platelets vulnerable to cardiopulmonary bypass. J Thorac Cardiovasc Surg in press
• 17 Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoprotein. Blood 77: 5-19 1991;
• 18 Ruggeri ZM. Mechanism of shear-induced platelet adhesion and aggregation. Thromb Haemost 70: 119-123 1993;
• 19 Slack SM, Cui Y, Turitto VT. The effects of flow on blood coagulation and thrombosis. Thromb Haemost 70: 129-134 1993;
• 20 Guyton. Textbook of Medical Physiology. . Saunders; Philadelphia: 1986: 218-229
• 21 Despotis GJ, Santoro SA, Spitznagel E, Kater KM, Cox JL, Barnes P, Lappas DG. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 107: 271-279 1994;
• 22 Tabuchi N, de Haan J, van Oeveren W. Topical effect of aprotinin on the surgical wound. J Thorac Cardiovasc Surg in press
• 23 Najafi H. Reoperation for excessive bleeding after cardiac operations. J Thorac Cardiovasc Surg 103: 814-824 1992;
• 24 Martinowitz U, Goor DA, Ramot B, Mohr R. Is transfusion of fresh plasma after cardiac operation indicated?. J Thorac Cardiovasc Surg 100: 92-98 1990;